A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population

Med. 2023 Jan 13;4(1):51-66.e10. doi: 10.1016/j.medj.2022.10.003. Epub 2022 Nov 16.


Background: Human induced pluripotent stem cells (iPSCs) are expected to be useful for regenerative medicine for many diseases. Many researchers have focused on and enabled the generation of differentiated cells or tissue-like structures, including organoids, which help to ameliorate target diseases. To promote such cell therapies, we established a clinically applicable iPSC haplobank matching as many people as possible in Japan.

Methods: Through cooperation with several organizations, we recruited donors whose human leukocyte antigens (HLAs) involved in immunorejection were homozygous. The peripheral or umbilical cord blood collected from the donors was used for iPSC production by electroporation of episomal vectors. These iPSC lines were then subjected to testing, including genome analyses and sterility, to maximize safety.

Findings: We constructed a clinical-grade haplobank of 27 iPSC lines from 7 donors according to good manufacturing practice regulations. However, reasons to avoid using iPSC lines include the presence of residual episomal vectors or genetic mutations in cancer-related genes.

Conclusions: This haplobank provides HLA-matched iPSC lines for approximately 40% of the Japanese population. Since the haplobank's release in 2015, these iPSC lines have been used in more than 10 clinical trials. The establishment of this haplobank is an important step toward the clinical application of iPSCs in cell therapies.

Funding: This study was supported by a research center network for the realization of regenerative medicine of the Japan Agency for Medical Research and Development (AMED) under grant number JP20bm0104001h0108.

Keywords: Foundational research; HLA haplobank; clinical-grade hiPSCs; genomic mutation; good manufacturing practice; residual vector.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • East Asian People
  • HLA Antigens / genetics
  • HLA Antigens / metabolism
  • Homozygote
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism


  • HLA Antigens